Support the FIND Act

The bi-partisan Facilitating Innovative Nuclear Diagnostics (FIND) Act will ensure patient access to these imaging procedures. 

Act Now!

Check out SNMMI-TV

Hear from SNMMI leadership, researchers, and patient advocates about what they're up to at the 2024 Annual Meeting.

View SNMMI-TV

SNMMI News Explore All News

SNMMI 2024 Annual Meeting Spotlights Cutting-Edge Research, Spurring Innovation Across the Field

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) hosted more than 8,000 physicians, technologists, pharmacists, laboratory professionals, scientists and others earlier this week at its 2024 Annual Meeting in Toronto, Ontario. Themed “Inn

New Chelating Agent Reduces Toxicity in PSMA Radiopharmaceutical Therapy

A newly developed chelator can significantly reduce off-target toxicity in prostate-specific membrane antigen (PSMA) radiopharmaceutical therapy, according to research presented at the 2024 Society of Nuclear Medicine and Molecular Imaging Annual Mee

FAPI PET/CT Improves Staging of Newly Diagnosed Breast Cancer

A comparative analysis between FAPI and 18F-FDG PET/CT for the systemic staging of newly diagnosed breast cancer shows that FAPI PET/CT is more accurate in staging patients. Nearly 20 percent of patients were restaged by FAPI PET/CT, indicating the r

Latest Journals